Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8473479 | Journal of Molecular and Cellular Cardiology | 2018 | 4 Pages |
Abstract
No-reflow phenomenon is defined as the reduced blood flow after myocardial ischemia. If prolonged it leads to profound damages in the myocardium. The lack of a detailed knowledge about the cells mediating no-reflow restricts the design of effective therapies. Recently, O'Farrell et al. (2017) by using state-of-the-art technologies, including high-resolution confocal imaging in combination with myocardial ischemia/reperfusion mouse model, reveal that pericytes contribute to the no-reflow phenomenon post-ischemia in the heart. Strikingly, intravenous adenosine increased vascular diameter at pericyte site after cardiac ischemia. This study provides a novel therapeutic target to inhibit no-reflow phenomenon after myocardial ischemia.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Matheus A. Costa, Ana E. Paiva, Julia P. Andreotti, Marcus V. Cardoso, Carlos D. Cardoso, Akiva Mintz, Alexander Birbrair,